3Longa ZE, Philp R, Weinstein PR, et al. Reversible cerebral artery occlusion without craniectomy in rats[J].Soroke, 1989, 20(1):84 - 91.
4Tanaka M. Pharmacological and clinical profile of the free radical scavenger edaravone as a neurop-rotective agent [J]. Nippon Yakurigaku Zasshi, 2002, 119: 301.
5Toyoda K, Fujii K, Kamouchi M, et al. Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion[J]. Neurol Sci, 2004, 15, 221(1-2): 11- 17.
6Edaravone Acute Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acutebrain infarction. Randomized, place-bo-controlled,double-blind study at multicenters[J]. Cerebrovasc Dis,2003,15:222.
7Mizuno A, Takahas M, Taylor G, et al. Inhibitory effect of MIC- 186, a free radical scavenger, on cerebral ischemia following rat middle cereral artery occlusion [J].Gen Phamacol, 1998, 30(2): 575-578.
8Yamamoto T, Stengelin S, Gimbrane MA, et al. Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in transient cerebral ischemia[J]. Brain Res, 1997, 762(3):240-242.
9Antic M,Lautenschlager S,Itin PH. Eosinophilic fasciitis 30 years after - what do we really know? Report of 11 patients and review of the literature [J]. Dermatology, 2006,213(2) :93-101.
10Lamloum M,Sioud DA,Ben Ghorbel I,et al. Shulman syndrome. A report of 4 cases and review of the literature [J ].Tunis Med, 2006,84(3 ) : 189-194.
